Müller glial cell reactivation in Xenopus models of retinal degeneration. 2017

Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
Paris-Saclay Institute of Neuroscience, CNRS, Univ Paris Sud, Université Paris-Saclay, Orsay, 91405, France.

A striking aspect of tissue regeneration is its uneven distribution among different animal classes, both in terms of modalities and efficiency. The retina does not escape the rule, exhibiting extraordinary self-repair properties in anamniote species but extremely limited ones in mammals. Among cellular sources prone to contribute to retinal regeneration are Müller glial cells, which in teleosts have been known for a decade to re-acquire a stem/progenitor state and regenerate retinal neurons following injury. As their regenerative potential was hitherto unexplored in amphibians, we tackled this issue using two Xenopus retinal injury paradigms we implemented: a mechanical needle poke injury and a transgenic model allowing for conditional photoreceptor cell ablation. These models revealed that Müller cells are indeed able to proliferate and replace lost cells following damage/degeneration in the retina. Interestingly, the extent of cell cycle re-entry appears dependent on the age of the animal, with a refractory period in early tadpole stages. Our findings pave the way for future studies aimed at identifying the molecular cues that either sustain or constrain the recruitment of Müller glia, an issue of utmost importance to set up therapeutic strategies for eye regenerative medicine.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D012038 Regeneration The physiological renewal, repair, or replacement of tissue. Endogenous Regeneration,Regeneration, Endogenous,Regenerations
D012162 Retinal Degeneration A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304) Degeneration, Retinal,Degenerations, Retinal,Retinal Degenerations
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
January 2016, Visual neuroscience,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
January 2007, Developmental dynamics : an official publication of the American Association of Anatomists,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
January 2003, Neuroscience,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
September 2016, Experimental eye research,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
September 1988, Investigative ophthalmology & visual science,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
January 2012, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
April 2008, Current eye research,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
September 2021, Glia,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
January 2023, Advances in ophthalmology practice and research,
Rahul Langhe, and Albert Chesneau, and Gabriele Colozza, and Magdalena Hidalgo, and Divya Ail, and Morgane Locker, and Muriel Perron
January 2013, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!